5 days Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

REGN’s lead drug, Eylea, faces a rapid decline in sales, which has impacted overall performance, even though Dupixent maintains momentum. We advise investors to wait and watch for now.

Pharmaceuticals · Regeneron Pharma (REGN)

5 days Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks

36 mins Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com

20 hours Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

21 hours NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

22 hours 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks

23 hours Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks

2 days Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks

2 days BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks

3 days Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha

3 days Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha

6 days Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? Zacks

6 days Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report? Zacks

7 days Phathom Pharmaceuticals: The Large Drop Is, Well, Unfathomable Seeking Alpha

7 days Reviva Pharmaceuticals: Upcoming Events May Generate Excitement, But Cash Is Low Seeking Alpha

7 days Vertex Pharmaceuticals: Progress Check Suggests Stock Remains A Solid Buy Seeking Alpha

7 days How Much Upside is Left in Ionis Pharmaceuticals (IONS)? Wall Street Analysts Think 55.91% Zacks

1 week Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know Zacks

1 week Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations Seeking Alpha

1 week Here’s Why Agios Stock Plummeted More Than 20% on Monday Zacks

1 week Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options Zacks

1 week Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Zacks

1 week BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy Seeking Alpha

1 week Agios Crashes 21% After A Surprise Side Effect Hammered Its ‘Very Safe’ Drug Investor's Business Daily

1 week Catalyst Pharmaceuticals: Agamree Is Its Key To A Sustainable Future Seeking Alpha

2 weeks Rhythm Pharmaceuticals: A Key Year Ahead Seeking Alpha

2 weeks Ionis Pharmaceuticals (IONS) Down 4.5% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Acadia (ACAD) Down 2.9% Since Last Earnings Report: Can It Rebound? Zacks

2 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

2 weeks Down -54.05% in 4 Weeks, Here’s Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a Turnaround Zacks

2 weeks Regeneron Pharmaceuticals, Inc. (REGN) Piper Sandler 36th Annual Healthcare Conference (Transcript) Seeking Alpha

2 weeks Why Is Apellis Pharmaceuticals (APLS) Up 18.4% Since Last Earnings Report? Zacks

2 weeks Are Options Traders Betting on a Big Move in Agios (AGIO) Stock? Zacks

2 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily

2 weeks What Makes Alnylam (ALNY) a New Buy Stock Zacks

2 weeks Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report? Zacks

2 weeks Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet Zacks

2 weeks Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know Zacks

2 weeks Agios Pharmaceuticals: A Long Overdue Follow Up Seeking Alpha

2 weeks Why Acadia Pharmaceuticals (ACAD) is a Top Momentum Stock for the Long-Term Zacks

2 weeks Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock Zacks

2 weeks Implied Volatility Surging for ACADIA Pharmaceuticals (ACAD) Stock Options Zacks

2 weeks Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial MarketWatch

2 weeks Coherus BioSciences inks $558.4M deal with Intas Pharmaceuticals; shares rally Investing.com

2 weeks Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks

2 weeks Rocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks Remain Seeking Alpha

2 weeks Elite Pharmaceuticals Launches Norco in generic $ELTP Reddit

3 weeks GILD vs. VRTX: Which Stock Should Value Investors Buy Now? Zacks

3 weeks Mirum Shares Surge More Than 90% in 6 Months: Here’s Why Zacks

3 weeks Wall Street Analysts Think Jazz (JAZZ) Could Surge 44.37%: Read This Before Placing a Bet Zacks

3 weeks Arrowhead Pharmaceuticals Faces Distribution Risks with Vanscoy Reliance Yahoo Finance

3 weeks Here’s Why Acurx Pharmaceuticals (ACXP) Is a Great ‘Buy the Bottom’ Stock Now Zacks

The Stock Market News